Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $190M | Buy |
3,620,294
+69,390
| +2% | +$3.67M | ﹤0.01% | 1830 |
|
|
2026
Q1 | $196M | Buy |
3,550,904
+1,736,715
| +96% | +$94.1M | ﹤0.01% | 1683 |
|
|
2025
Q4 | $89M | Sell |
1,814,189
-160,034
| -8% | -$7.46M | ﹤0.01% | 2175 |
|
|
2025
Q3 | $85.2M | Buy |
1,974,223
+369,994
| +23% | +$14.5M | ﹤0.01% | 2197 |
|
|
2025
Q2 | $61.6M | Sell |
1,604,229
-16,710
| -1% | -$639K | ﹤0.01% | 2333 |
|
|
2025
Q1 | $62.8M | Buy |
1,620,939
+74,093
| +5% | +$2.71M | ﹤0.01% | 2256 |
|
|
2024
Q4 | $52.3M | Sell |
1,546,846
-45,352
| -3% | -$1.63M | ﹤0.01% | 2424 |
|
|
2024
Q3 | $65.1M | Sell |
1,592,198
-87,558
| -5% | -$3.58M | ﹤0.01% | 2323 |
|
|
2024
Q2 | $64.7M | Sell |
1,679,756
-117,574
| -7% | -$4.95M | ﹤0.01% | 2269 |
|
|
2024
Q1 | $77.1M | Buy |
1,797,330
+317,016
| +21% | +$13.1M | ﹤0.01% | 2209 |
|
|
2023
Q4 | $54.9M | Sell |
1,480,314
-36,201
| -2% | -$1.3M | ﹤0.01% | 2420 |
|
|
2023
Q3 | $55M | Buy |
1,516,515
+52,404
| +4% | +$1.86M | ﹤0.01% | 2346 |
|
|
2023
Q2 | $52.2M | Buy |
1,464,111
+91,972
| +7% | +$3.3M | ﹤0.01% | 2458 |
|
|
2023
Q1 | $48.8M | Buy |
1,372,139
+194,209
| +16% | +$6.79M | ﹤0.01% | 2462 |
|
|
2022
Q4 | $41.4M | Buy |
1,177,930
+352,769
| +43% | +$11.8M | ﹤0.01% | 2598 |
|
|
2022
Q3 | $24.3M | Sell |
825,161
-123,019
| -13% | -$4.66M | ﹤0.01% | 2927 |
|
|
2022
Q2 | $51.6M | Buy |
948,180
+54,075
| +6% | +$2.99M | ﹤0.01% | 2476 |
|
|
2022
Q1 | $48.7M | Sell |
894,105
-6,496
| -0.7% | -$353K | ﹤0.01% | 2608 |
|
|
2021
Q4 | $49.6M | Buy |
900,601
+100,785
| +13% | +$5.24M | ﹤0.01% | 2669 |
|
|
2021
Q3 | $38.2M | Buy |
799,816
+63,114
| +9% | +$3.17M | ﹤0.01% | 2840 |
|
|
2021
Q2 | $36.7M | Buy |
736,702
+151,538
| +26% | +$7.28M | ﹤0.01% | 2901 |
|
|
2021
Q1 | $26.1M | Buy |
585,164
+581,908
| +17,872% | +$26.4M | ﹤0.01% | 3039 |
|
|
2020
Q4 | $150K | Sell |
3,256
-468,169
| -99% | -$21.5M | ﹤0.01% | 4519 |
|
|
2020
Q3 | $22.2M | Sell |
471,425
-448,409
| -49% | -$22.5M | ﹤0.01% | 2801 |
|
|
2020
Q2 | $46.9M | Sell |
919,834
-199,158
| -18% | -$10.2M | ﹤0.01% | 2286 |
|
|
2020
Q1 | $53M | Sell |
1,118,992
-294,880
| -21% | -$15.7M | ﹤0.01% | 2002 |
|
|
2019
Q4 | $83M | Buy |
1,413,872
+202,504
| +17% | +$11.3M | ﹤0.01% | 2063 |
|
|
2019
Q3 | $64.6M | Sell |
1,211,368
-10,316
| -0.8% | -$531K | ﹤0.01% | 2141 |
|
|
2019
Q2 | $61.1M | Buy |
1,221,684
+185,813
| +18% | +$9.32M | ﹤0.01% | 2214 |
|
|
2019
Q1 | $54.1M | Buy |
1,035,871
+90,638
| +10% | +$4.53M | ﹤0.01% | 2230 |
|
|
2018
Q4 | $45.1M | Sell |
945,233
-192,429
| -17% | -$9.48M | ﹤0.01% | 2303 |
|
|
2018
Q3 | $57.1M | Sell |
1,137,662
-124,015
| -10% | -$6.3M | ﹤0.01% | 2304 |
|
|
2018
Q2 | $63.6M | Buy |
1,261,677
+240,923
| +24% | +$12.1M | ﹤0.01% | 2229 |
|
|
2018
Q1 | $49.9M | Buy |
1,020,754
+363,644
| +55% | +$16.9M | ﹤0.01% | 2271 |
|
|
2017
Q4 | $29.1M | Sell |
657,110
-294,999
| -31% | -$13.6M | ﹤0.01% | 2584 |
|
|
2017
Q3 | $48.3M | Buy |
952,109
+163,271
| +21% | +$8.28M | ﹤0.01% | 2319 |
|
|
2017
Q2 | $42.5M | Buy |
788,838
+170,508
| +28% | +$9.09M | ﹤0.01% | 2354 |
|
|
2017
Q1 | $32.6M | Buy |
618,330
+617,450
| +70,165% | +$31.3M | ﹤0.01% | 2469 |
|
|
2016
Q4 | $42K | Buy |
880
+480
| +120% | +$23.7K | ﹤0.01% | 3016 |
|
|
2016
Q3 | $22K | Hold |
400
| – | – | ﹤0.01% | 3265 |
|
|
2016
Q2 | $22K | Sell |
400
-80
| -17% | -$4.21K | ﹤0.01% | 3241 |
|
|
2016
Q1 | $24K | Sell |
480
-160
| -25% | -$7.97K | ﹤0.01% | 2763 |
|
|
2015
Q4 | $32K | Buy |
+640
| New | +$32.6K | ﹤0.01% | 2323 |
|
|
2013
Q4 | – | Sell |
-2,000
| Closed | -$125K | – | 3133 |
|
|
2013
Q3 | $125K | Hold |
2,000
| – | – | ﹤0.01% | 1608 |
|
|
2013
Q2 | $125K | Buy |
+2,000
| New | +$127K | ﹤0.01% | 1614 |
|
Other funds holding GSK
JEST
BlackRock's GSK Position: Q2 2026 in Review
BlackRock increased its GSK (GSK) stake by 2% in Q2 2026, buying an estimated $3.67M and bringing the position to 3,620,294 shares worth $190M. The position accounts for ﹤0.01% of the portfolio, ranked #1830.
BlackRock first reported a position in GSK in Q2 2013 and has held it in 45 quarters since. The position peaked at $196M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- BlackRock held 3,620,294 shares of GSK worth $190M as of Q2 2026.
- BlackRock bought 69,390 GSK shares in Q2 2026, an estimated $3.67M.
- GSK made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1830 holding.
- BlackRock first reported a position in GSK in Q2 2013 and has held it in 45 quarters since.
- BlackRock's GSK position peaked at $196M in Q1 2026.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.